Fluorothiazinone

N/A

Report date: 2025/05/28 11:25:50
NME

Base Information

Drug NameFluorothiazinone
Drug Alias NameFluorothiazinonFluorothyazinoneFtortiazinonCL-55
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionType III secretion system protein inhibitors
TargetsType III secretion system protein
Therapy Area/IndicationsEnterococcus Faecalis InfectionsAcinetobacter Baumannii InfectionsCystitis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation
China Registration ClassN/A

Develop Information

Active CompaniesGamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation
Inactive CompaniesN/A
Active IndicationsEnterococcus Faecalis InfectionsAcinetobacter Baumannii InfectionsCystitis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A